LH
LHC.JSE Life Healthcare
- Market cap
- ZAC 18.1B
- P/E
- 1,366.7x
- P/B
- 162.99x
- ROE
- 27.3%
- Dividend yield
- 4.57%
- Fundamental score
- 3.2/5
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.
Is LHC.JSE undervalued?
Graham numberThe Graham number of Life Healthcare cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Life Healthcare fundamental analysis
15 of 22 checks passedROE 2/2
High return on equity (27.3%), above 20%.
ROA 1/1
Return on assets (13.2%) is above the industry median (5.9%).
Profit Consistency 2/2
Profitable for 10 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Last year's EPS growth (-19.9%) is not above the 5-year average (152.3% a year).
Earnings Growth vs Industry 0/1
Last year's EPS growth (-19.9%) is below the industry median (-19.9%).
Revenue Growth 1/2
Revenue grew 6.9% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 0/1
Current assets do not cover long-term liabilities.
Debt to Equity 1/2
Moderate debt to equity (42.6%), up to 100%.
Debt Trend 1/1
Debt to equity has not risen over the past 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 1/1
EBIT is 5.8x against interest expense, well covered.
PE vs Market 0/1
PE (13.6x) is above the market median (9.1x).
PE vs Industry 1/1
PE (13.6x) is below the industry median (22.9x).
PBV 0/1
Price to book (1.6x) is above the industry median (1.4x).
Graham Number 1/1
The price is below the Graham number (PE x PB = 22.1, limit 22.5).
PEG 1/1
PEG on 5-year earnings growth is 0.09, growth is cheap.
Dividend Yield 2/2
Dividend yield (9.9%) is in the top 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 1/1
Dividends paid grew over the past 5 years.
Payout Ratio 0/1
Payout ratio is 135.4%, above 90% of earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Life Healthcare stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Life Healthcare
Life Healthcare Group Holdings Limited, an investment holding company, operates as a private healthcare company in Southern Africa. It operates through Southern Africa " Hospitals Services, Southern Africa - Complementary Services, Southern Africa - Healthcare Services, and International segments. The company operates acute hospitals; and Life Nkanyisa care centres that provide long-term chronic mental healthcare, frail care rehabilitation, step-down care, correctional servi…
Full company profileLife Healthcare financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Life Healthcare annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 16.4B | 20.8B | 23.5B | 25.7B | 25.4B | 26.9B | 20.5B | 22.6B | 25.8B | 25.1B | 49.7B |
| Gross Profit | 11.6B | 14.9B | 16.6B | 18.1B | 17.7B | 18.3B | 5.87B | 5.45B | 7.75B | 17.2B | 11.6B |
| Operating Income | 3.66B | 3.62B | 3.85B | 3.94B | 2.18B | 3.01B | 2.76B | 2.44B | 2.90B | -508M | 4.58B |
| EBITDA | 4.05B | 4.66B | 5.58B | 6.28B | 4.16B | 5.06B | 3.53B | 3.62B | 4.37B | 1.04B | 7.25B |
| Net Income | 1.62B | 814M | 1.58B | 2.57B | 38.0M | 1.75B | 1.53B | 264M | 4.83B | 3.86B | 3.08B |
| EPS | 1.44 | 0.62 | 1.08 | 1.76 | 0.03 | 1.20 | 1.05 | 0.18 | 3.32 | 2.66 | 2.13 |
| Balance Sheet | |||||||||||
| Total Assets | 17.5B | 36.6B | 39.1B | 37.6B | 42.7B | 40.8B | 42.2B | 45.6B | 24.3B | 25.7B | 23.4B |
| Total Liabilities | 10.7B | 21.1B | 22.9B | 20.1B | 24.4B | 21.6B | 22.4B | 24.3B | 10.8B | 13.5B | 11.5B |
| Shareholders' Equity | 5.49B | 14.4B | 14.9B | 16.2B | 17.1B | 18.1B | 18.7B | 20.2B | 12.5B | 11.4B | 11.3B |
| Cash & Short-term Investments | 604M | 1.18B | 1.49B | 1.54B | 2.28B | 2.67B | 2.80B | 846M | 2.46B | 3.81B | 1.13B |
| Total Debt | 5.26B | 10.6B | 13.7B | 12.4B | 16.4B | 12.6B | 13.7B | 13.2B | 4.42B | 3.95B | 4.81B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 3.06B | 3.72B | 4.44B | 4.66B | 4.04B | 5.14B | 4.23B | 4.67B | 3.72B | 4.04B | 3.97B |
| Capital Expenditure | 1.01B | 1.66B | 2.24B | 2.06B | 1.96B | 1.90B | 2.35B | 1.21B | 1.55B | 1.81B | 2.71B |
| Free Cash Flow | 2.04B | 2.07B | 2.20B | 2.60B | 2.08B | 3.24B | 1.88B | 3.46B | 2.17B | 2.62B | 1.26B |
| Ratios | |||||||||||
| ROE | 29.5% | 5.7% | 10.6% | 15.9% | 0.2% | 9.7% | 8.2% | 1.3% | 38.5% | 34.0% | 27.3% |
| ROA | 9.2% | 2.2% | 4.0% | 6.8% | 0.1% | 4.3% | 3.6% | 0.6% | 19.8% | 15.0% | 13.2% |
| Net Profit Margin | 9.9% | 3.9% | 6.7% | 10.0% | 0.1% | 6.5% | 7.5% | 1.2% | 18.7% | 15.4% | 6.2% |
| Debt to Equity | 0.96x | 0.74x | 0.92x | 0.76x | 0.96x | 0.69x | 0.73x | 0.65x | 0.35x | 0.35x | 0.43x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Life Healthcare dividends
- Dividend yield
- 4.57%
- Forward dividend
- 0.58 ZAC
- Payout ratio
- 135.4%
- Ex-dividend date
- Jun 17, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | ZAR 5.23B | 3.60 | 135.4% |
| 2024 | ZAR 9.47B | 6.52 | 196.2% |
| 2023 | ZAR 616M | 0.42 | 233.3% |
| 2022 | ZAR 587M | 0.40 | 38.3% |
| 2021 | ZAR 587M | 0.40 | 33.5% |
| 2020 | ZAR 778M | 0.53 | 2,047.4% |
| 2019 | ZAR 1.32B | 0.90 | 51.4% |
| 2018 | ZAR 758M | 0.52 | 48.1% |
| 2017 | ZAR 765M | 0.58 | 94.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 273:254 on Mar 29, 2017.
Who owns Life Healthcare
- Insiders 0.00%
- Institutions 86.28%
- Public & others 13.72%
- Shares outstanding 1.43B
- Free float 1.41B
Life Healthcare company profile
- Company name
- Life Healthcare
- Ticker
- LHC.JSE
- ISIN
- ZAE000145892
- Exchange
- Johannesburg Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Fiscal year end
- September
- Address
- Oxford Parks, Johannesburg, South Africa, 2196
- Phone
- 27 11 219 9000
- Website
- lifehealthcare.co.za
About Life Healthcare
Life Healthcare Group Holdings Limited, an investment holding company, operates as a private healthcare company in Southern Africa. It operates through Southern Africa " Hospitals Services, Southern Africa - Complementary Services, Southern Africa - Healthcare Services, and International segments. The company operates acute hospitals; and Life Nkanyisa care centres that provide long-term chronic mental healthcare, frail care rehabilitation, step-down care, correctional services, primary healthcare, and substance abuse recovery programme services to patients in the public sector. It also offers mental health, acute rehabilitation, renal dialysis, oncology, and diagnostics services; and training for pharmacists, pharmacists' assistants, and nurses. In addition, the company provides nursing and pharmacy services; and health and well-being, occupational health, emergency medical, and complementary and advisory services. Further, it retains the right to manufacture, commercialise, and distribute Life Molecular Imaging (LMI) products, such as early-stage novel radiotherapeutic and radio diagnostic products in Africa. The company was formerly known as Afrox Healthcare Limited and changed its name to Life Healthcare Group Holdings Limited in January 2005. Life Healthcare Group Holdings Limited was founded in 1983 and is headquartered in Johannesburg, South Africa.
Life Healthcare management
10- Mr. Peter Gerard Wharton-Hood AMP Harvard, BCom (Hons), CA(SA)CEO & Executive Director · born 1966
- Mr. Pieter Phillippus van der Westhuizen CA(SA)CFO & Executive Director · born 1971
- Mr. Craig Ian KoekemoerChief Operations Officer
- Mr. David Price B.Sc., M.B.A.Chief Information Officer
- Ms. Avanthi ParboosingChief People Officer · born 1976
- Ms. Merle VictorChief Nurse Officer
- Dr. Karisha QuarrieChief Medical Officer
- Mr. Brett MillChief Actuary & Risk Officer
- Ms. Joshila Ranchhod B.A., L.L.B.Group Company Secretary
- Mr. Guy E. BlomfieldNon-Executive Director of Life UK · born 1968